Browse drugs

… as well as pathway analysis using MsigDB. Patient outcomes for docetaxel and atezolizumab were assessed in OAK and POPLAR clinical trial…

…after surgery, neoadjuvant nivolumab prior to surgery, adjuvant pembrolizumab and atezolizumab after surgery, perioperative durvalumab and pe…

…GF-A/VEGFR-1 loop within macrophages.Conclusion The addition of bevacizumab to chemoimmunotherapy was associated with improved survival in …

…poor. The PERICLES study explored a novel strategy of combining atezolizumab with radiation therapy for patients with advanced PeCa. 65 Howe…

… therapy with atezolizumab, an immune checkpoint inhibitor, and bevacizumab, a vascular endothelial growth factor (VEGF) inhibitor. Three d…

…atients, with durable responses to combination regimens such as atezolizumab plus bevacizumab occurring in a minority.1 2 Neutrophils, long …

…immune checkpoint blockade (ICB). Since the landmark success of atezolizumab plus bevacizumab in the IMbrave150 trial, immunotherapy has bec…

…ed clinical outcomes in an external patient cohort treated with atezolizumab plus bevacizumab.Conclusions These findings establish PDOTS as …

…Background Atezolizumab plus bevacizumab (Atez/Bev) has become the first-line therapy f…

…Background Combination immunotherapies such as atezolizumab plus bevacizumab (Atez/Bev) and durvalumab plus tremelimumab (D…

…ucted, including all patients who received at least one dose of pembrolizumab, nivolumab, or atezolizumab as first-line treatment for metasta…

…Results In 2023 and 2024 we used seven immunotherapeutic drugs: pembrolizumab (230 patients), durvalumab (45 patients), atezolizumab (45 pati…